Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. (Q37649575)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

review article

1 reference

title

Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Tohru Utsunomiya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mitsuo Shimada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Satoru Imura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yuji Morine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Masaki Mori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

8 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

146-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease

14 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-009-0164-1

Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients

21 January 2018

1 reference

12 December 2020

Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma

1 reference

12 December 2020

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

12 December 2020

A gene-expression signature can quantify the degree of hepatic fibrosis in the rat.

1 reference

12 December 2020

Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma

1 reference

12 December 2020

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

1 reference

12 December 2020

Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

1 reference

12 December 2020

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma

1 reference

12 December 2020

Preoperative assessment of multicentric occurrence in synchronous small and multiple hepatocellular carcinoma based on image-patterns and histological grading of non-cancerous region

1 reference

12 December 2020

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

12 December 2020

Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells

1 reference

12 December 2020

Sorafenib in advanced hepatocellular carcinoma

1 reference

12 December 2020

Multistep human hepatocarcinogenesis: correlation of imaging with pathology

1 reference

12 December 2020

Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.

1 reference

12 December 2020

Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

1 reference

12 December 2020

Importance of field cancerisation in clinical oncology.

1 reference

12 December 2020

Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study

1 reference

12 December 2020

Molecular-based prediction of early recurrence in hepatocellular carcinoma

1 reference

12 December 2020

Recent advances in the pathogenesis and diagnosis of liver fibrosis

1 reference

12 December 2020

Early HCC: diagnosis and molecular markers

1 reference

12 December 2020

Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Viruses and hepatocellular carcinoma

1 reference

12 December 2020

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

12 December 2020

Translational microarray systems for outcome prediction of hepatocellular carcinoma

1 reference

12 December 2020

Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan

1 reference

12 December 2020

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach

1 reference

12 December 2020

Op18/stathmin mediates multiple region-specific tubulin and microtubule-regulating activities

1 reference

12 December 2020

Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

1 reference

12 December 2020

Molecular prediction of early recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

1 reference

12 December 2020

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

1 reference

12 December 2020

Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis

1 reference

12 December 2020

A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy.

1 reference

12 December 2020

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

1 reference

12 December 2020

Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma

1 reference

12 December 2020

Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray.

1 reference

12 December 2020

Predicting individual outcomes in hepatocellular carcinoma

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

10.1007/S00535-009-0164-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997856%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference